• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Model Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Reaction (2414); Patient Problem/Medical Problem (2688)
Event Date 04/16/2019
Event Type  Injury  
Manufacturer Narrative
Event date is approximate (reported that issue noted approximately 1 week prior to (b)(6) follow up).If information is provided in the future, a supplemental report will be issued.
 
Event Description
The physician used venaseal to successfully treat a 53cm segment of the left great saphenous vein (gsv).A separate procedure was previously performed on the right gsv the ifu was followed and the procedure was completed normally and no additional treatment was required.The patient did not have any pain during the procedure.The patient had a dvt check on (b)(6) 2019 which was negative.It was reported that the patient experienced a skin irritation or burn one week prior to the (b)(6) visit.On (b)(6) the patient presented with two red hardened areas which had abscessed on the left leg and one on the right leg.The abscess was drained and hardened over.
 
Manufacturer Narrative
This patient had 4 venaseal procedures over two weeks in january 2019.This reaction, as associated with both legs have been reported per procedure.A 23cm segment of the patient¿s right small saphenous vein (ssv) was treated and compression was applied.The tip of the venaseal was 5cm caudal to the sfj, the procedure was completed normally, and no additional treatment was required.A mild reaction was noted on one week post the dvt check.A steroid dose pak was prescribed.This was noted to be resolved 9 days post prescription of the steroid dose pak.The patient returned for follow-up visit one-month post resolution of mild reaction with the abscess.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Image review: one image was received from the customer.Per the image, there is evidence of redness and abscessed at the treated site.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8598753
MDR Text Key144661110
Report Number9612164-2019-01654
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 06/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2020
Device Model NumberVS-402
Device Catalogue NumberVS-402
Device Lot Number52838
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/30/2019
Date Device Manufactured09/21/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-